Azithromycin

• 

  Subject Areas on Research

  • A cost-minimization analysis comparing azithromycin-based and levofloxacin-based protocols for the treatment of patients hospitalized with community-acquired pneumonia: results from the CAP-IN trial. 
  • A time-kill evaluation of clarithromycin and azithromycin against two extracellular pathogens and the development of resistance. 
  • An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome. 
  • Analysis of the potential for point-of-care test to enable individualised treatment of infections caused by antimicrobial-resistant and susceptible strains of Neisseria gonorrhoeae : a modelling study. 
  • Antibiotics for Prophylaxis in the Setting of Preterm Prelabor Rupture of Membranes. 
  • Antimicrobial-Resistant Shigella spp. in San Diego, California, USA, 2017-2020. 
  • Atraumatic splenic rupture from Babesia: A disease of the otherwise healthy patient. 
  • Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial. 
  • Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial. 
  • Azithromycin use increases the risk of sudden cardiac death in patients with hemodialysis-dependent kidney failure. 
  • Azithromycin--spectrum of activity, pharmacokinetics, and clinical applications. 
  • Case Report: Gonorrhea as a Cause of Exudative Tonsillitis. 
  • Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. 
  • Conjunctival pseudotumor caused by herpes simplex virus infection. 
  • Disseminated Mycobacterium kansasii disease in complete DiGeorge syndrome. 
  • Effect of Azithromycin on Venetoclax Pharmacokinetics in Healthy Volunteers: Implications for Dosing Venetoclax with P-gp Inhibitors. 
  • Effect of topical azithromycin on corneal innate immune responses. 
  • Effectiveness of antimicrobial guidelines for community-acquired pneumonia in children. 
  • Efficacy and safety of azithromycin versus placebo to treat lower respiratory tract infections associated with low procalcitonin: a randomised, placebo-controlled, double-blind, non-inferiority trial. 
  • Evaluating Guideline-Recommended Antibiotic Practices for Childhood Respiratory Infections: Is It Time to Consider Case-Based Formats? 
  • Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19. 
  • Inhaled azithromycin therapy. 
  • Mass drug administration of antibacterials: weighing the evidence regarding benefits and risks. 
  • Maternal serum interleukin-6 levels predict impending funisitis in preterm premature rupture of membranes after completion of antibiotics. 
  • Plastic bronchitis: resolution after heart transplantation. 
  • Prevention of antibiotic-associated metabolic syndrome in mice by intestinal alkaline phosphatase. 
  • Recurrent expressive aphasia as a presentation of cat-scratch encephalopathy. 
  • Susceptibilities of neonatal respiratory isolates of Ureaplasma urealyticum to antimicrobial agents. 
  • The effect of chronic azithromycin therapy on soluble endothelium-derived adhesion molecules in patients with coronary artery disease. 
  • The effects of intravenous doxycycline therapy for rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial. 
  • Trachoma: an update on prevention, diagnosis, and treatment. 
  • Treatment of Mycobacterium abscessus: all macrolides are equal, but perhaps some are more equal than others. 
• 

  Keywords of People

  • O'Connor, Christopher Michael, Adjunct Professor in the Department of Medicine, Medicine, Clinical Pharmacology